| Americold Realty Trust, Inc. Sets Date for First Quarter 2026 Earnings Release and Conference Call |
Globe Newswire |
04/13 |
07:00 |
| Aeluma Secures More Than $4 Million in Contracts for Quantum Materials and Lasers |
Globe Newswire |
04/13 |
07:00 |
| Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma |
Globe Newswire |
04/13 |
07:00 |
| Abaxx Exchange Recognized as Organised Market Place by ACER |
Globe Newswire |
04/13 |
07:00 |
| ImageneBio Announces $30 Million Private Placement |
Globe Newswire |
04/13 |
07:00 |
| Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD |
Globe Newswire |
04/13 |
07:00 |
| $SMR Class Action Reminder: NuScale Power Investors are Reminded to Contact BFA Law after Company Sued for Securities Fraud Over ENTRA1 Issues |
Globe Newswire |
04/13 |
06:36 |
| Parsons Selected to Lead Design of $409M Roosevelt Bridge Replacement |
Globe Newswire |
04/13 |
06:30 |
| Regeneron and Telix Announce Strategic Radiopharma Collaboration |
Globe Newswire |
04/13 |
06:30 |
| EnviroGold Advances Critical Minerals Supply Opportunities Through Centralized Processing Hub Strategy |
Globe Newswire |
04/13 |
06:30 |
| Telix and Regeneron Announce Strategic Radiopharma Collaboration |
Globe Newswire |
04/13 |
06:30 |
| ORO Labs to Host Orchestrating Procurement for Impact Workshop at The US Summit |
Globe Newswire |
04/13 |
06:22 |
| Crypto.com launches “Level-Up” program to accelerate the world’s transition to cryptocurrency |
Globe Newswire |
04/13 |
06:04 |
| ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device |
Globe Newswire |
04/13 |
06:00 |
| BGIN BLOCKCHAIN LIMITED Announces Resolution of Subsidiary’s Hosting Dispute and Full Recovery of Mining Machines |
Globe Newswire |
04/13 |
06:00 |
| Vitaquest Fall 2026 Dietary Supplement Trends Report: Key Insights for Brands and Manufacturers |
Globe Newswire |
04/13 |
06:00 |
| Springboards Launches ‘Flint’ to Break AI’s Habit of Predictable, Boring Answers |
Globe Newswire |
04/13 |
06:00 |
| Over a third of Americans would accept twice as many ads for cheaper streaming |
Globe Newswire |
04/13 |
04:00 |
| Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows |
Globe Newswire |
04/13 |
03:51 |
| Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada |
Globe Newswire |
04/13 |
03:20 |
| CallTower Expands Channel Leadership with Two Key Director Appointments |
Globe Newswire |
04/13 |
03:00 |
| TaxTec, Proxymity and Label Launch End-to-End MiKaDiv Solution for Withholding Tax Compliance |
Globe Newswire |
04/13 |
02:53 |
| Baker Hughes Announces Sale of Waygate Technologies to Hexagon |
Globe Newswire |
04/13 |
02:00 |
| Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer |
Globe Newswire |
04/13 |
02:00 |
| SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT) |
Globe Newswire |
04/13 |
02:00 |
